Health and Healthcare

Thursday's Top Biotech and Medical Stocks

From BioHealth Investor

Biotechnology

PRAECIS PHARMA [PRCS] +144.51%
FERMAVIR PHARMACEUTL [FMVR.OB] +28.00%
POLYMEDIX INC [PYMX.OB] +23.08%
ACCENTIA BIOPHARMACE [ABPI] +17.59%
REXAHN PHARMACEUTICL [RXHN.OB] +17.39%

Diagnostic Substances

IMMUNOMEDICS INC [IMMU] +13.59%
AVALON PHARMACEUTIC [AVRX] +12.50%
ASPENBIO PHARMA INC [APNB.OB] +10.84%
REMOTEMDX INC [RMDX.OB] +7.75%
EPIX PHARMACEUTICALS [EPIX] +5.22%

Drug Delivery

BENTLEY PHARMACEUTIC [BNT] +9.18%
EMISPHERE TECH [EMIS] +6.63%
IOMED INC [IOX] +4.91%
SKYEPHARMA PLC [SKYE] +2.67%
NOVADEL PHARMA INC [NVD] +2.61%

Drug Manufacturers

PLANET TECHS INC [PLNT.OB] +33.33%
SEPRACOR INC [SEPR] +8.59%
COLLAGENEX PHARM I [CGPI] +4.90%
ALLOS THERAPEUTICS [ALTH] +2.94%
INTERPHARM HLDGS INC [IPA] +2.93%

Medical Appliances & Equipment

SYNERON MEDICAL LTD. [ELOS] +8.56%
ALPHA PRO TECH [APT] +5.30%
SPECTRANETICS CP T [SPNC] +5.22%
CELSION CORP [CLN] +5.13%
THERAGENICS CORP [TGX] +4.76%

Medical Instruments & Supplies

ENPATH MED INC [NPTH] +10.00%
ELECTRO-OPTICAL SCIE [MELA] +8.19%
ANGEION CORP [ANGN] +7.07%
CRYOCOR, INC. [CRYO] +5.58%
NEUROMETRIX, INC. [NURO] +4.56%

Medical Laboratories & Research

BIOFORCE NANOSCIENCE [BFNH.OB] +21.12% $0
MEDASORB TECHNOLOGS [MSBT.OB] +14.75% $0
ERESEARCHTECHNOLOG [ERES] +7.79% $632.6 M
ALLIANCE IMAGING INC [AIQ] +2.02% $531.8 M
PSYCHEMEDICS NEW [PMD] +1.60%

http://www.biohealthinvestor.com/

Smart Investors Are Quietly Loading Up on These “Dividend Legends”

If you want your portfolio to pay you cash like clockwork, it’s time to stop blindly following conventional wisdom like relying on Dividend Aristocrats. There’s a better option, and we want to show you. We’re offering a brand-new report on 2 stocks we believe offer the rare combination of a high dividend yield and significant stock appreciation upside. If you’re tired of feeling one step behind in this market, this free report is a must-read for you.

Click here to download your FREE copy of “2 Dividend Legends to Hold Forever” and start improving your portfolio today.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.